Apixaban or Vitamin K Antagonists for Stroke Prevention in Patients With Atrial Fibrillation on Hemodialysis: Results of the Randomized Axadia-AFNET 8 Trial

被引：0
|
作者：
Reinecke, Holger [1 ]
Bauersachs, Rupert [2 ]
Breithardt, Gunter [3 ]
Engelbertz, Christiane [3 ]
Gerss, Joachim [4 ]
Gaerlich, Dennis [4 ]
Juergensmeyer, Sabine [5 ]
Wanner, Christoph [6 ]
Kirchhof, Paulus [7 ]
机构：
[1] Univ Hosp Muenster, Dept Cardiol, Munster, Germany
[2] Agaples Bethanien Hosp, Med Care Cntr, Frankfurt, Germany
[3] Univ Hosp Muenster, Dept Cardiol, Munster, Germany
[4] Univ Munster, Inst Biostat & Clin Rsch, Munster, Germany
[5] Atrial Fibrillat Network, Munster, Germany
[6] Univ Hosp, Div Nephrol, Dept Med, Wurzburg, Germany
[7] Univ Hosp Hamburg Eppendorf, Dept Cardiol, Hamburg, Germany
来源：
CIRCULATION | 2022年 / 146卷 / 25期
关键词：
atrialfibrillation; apixaban; vitamin K antagonist; hemodialysis; randomized; controlled trial; stroke prevention;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
18519
引用
收藏
页码：E589 / E590
页数：2
相关论文
共 50 条
  • [1] A Randomized Controlled Trial Comparing Apixaban With the Vitamin K Antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 Study
    Reinecke, Holger
    Engelbertz, Christiane
    Bauersachs, Rupert
    Breithardt, Gunter
    Echterhoff, Hans-Herbert
    Gerss, Joachim
    Haeusler, Karl Georg
    Hewing, Bernd
    Hoyer, Joachim
    Juergensmeyer, Sabine
    Klingenheben, Thomas
    Knapp, Guido
    Rump, Lars Christian
    Schmidt-Guertler, Hans
    Wanner, Christoph
    Kirchhof, Paulus
    Goerlich, Dennis
    CIRCULATION, 2023, 147 (04) : 296 - 309
  • [2] Use of NOAK in hemodialysis patients with atrial fibrillation AXADIA-AFNET 8 study
    Kraemer, Bernhard K. K.
    Yazdani, Babak
    Kaelsch, Anna-Isabelle
    NEPHROLOGIE, 2023, 18 (05): : 319 - 320
  • [3] Design and rationale of a randomised controlled trial comparing apixaban to phenprocoumon in patients with atrial fibrillation on chronic haemodialysis: the AXADIA-AFNET 8 study
    Reinecke, Holger
    Juergensmeyer, Sabine
    Engelbertz, Christiane
    Gerss, Joachim
    Kirchhof, Paulus
    Breithardt, Guenter
    Bauersachs, Rupert
    Wanner, Christoph
    BMJ OPEN, 2018, 8 (09):
  • [4] Apixaban for stroke prevention in hemodialysis patients with nonvalvular atrial fibrillation
    Mavrakanas, Thomas A.
    KIDNEY INTERNATIONAL, 2023, 103 (06) : 1014 - 1017
  • [5] Vitamin K antagonists for stroke prevention in hemodialysis patients with atrial fibrillation: A systematic review and meta-analysis
    Van Der Meersch, Hans
    De Bacquer, Dirk
    De Vriese, An S.
    AMERICAN HEART JOURNAL, 2017, 184 : 37 - 46
  • [6] Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial
    Pokorney, Sean D.
    Chertow, Glenn M.
    Al-Khalidi, Hussein R.
    Gallup, Dianne
    Dignacco, Pat
    Mussina, Kurt
    Bansal, Nisha
    Gadegbeku, Crystal A.
    Garcia, David A.
    Garonzik, Samira
    Lopes, Renato D.
    Mahaffey, Kenneth W.
    Matsuda, Kelly
    Middleton, John P.
    Rymer, Jennifer A.
    Sands, George H.
    Thadhani, Ravi
    Thomas, Kevin L.
    Washam, Jeffrey B.
    Winkelmayer, Wolfgang C.
    Granger, Christopher B.
    CIRCULATION, 2022, 146 (23) : 1735 - 1745
  • [7] Should dabigatran or vitamin K antagonists be used in prevention of stroke in patients with atrial fibrillation?
    Calvo Romero, J. M.
    REVISTA CLINICA ESPANOLA, 2011, 211 (03): : 142 - 146
  • [8] Apixaban versus Warfarin for Stroke Prevention in Patients With End Stage Renal Disease on Hemodialysis and Atrial Fibrillation: Results of a Randomized Clinical Trial Assessing Safety
    Pokorney, Sean D.
    Chertow, Glenn M.
    Al-Khalidi, Hussein
    Gallup, Dianne
    Dignacco, Pat
    Mussina, Kurt
    Bansal, Nisha
    Gadegbeku, Crystal A.
    Garcia, David
    Jones-Burton, Charlotte
    Lopes, Renato D., Sr.
    Mahaffey, Kenneth W.
    Middleton, John
    Mills, Donna
    Rymer, Jennifer A.
    Thadhani, Ravi
    Thomas, Kevin L.
    Winkelmayer, Wolfgang C.
    Granger, Christopher B.
    CIRCULATION, 2019, 140 (25) : E988 - E989
  • [9] Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial
    De Vriese, An S.
    Caluwe, Rogier
    Van Der Meersch, Hans
    De Boeck, Koen
    De Bacquer, Dirk
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (06): : 1474 - 1483
  • [10] Clopidogrel or apixaban in atrial fibrillation patients unsuitable for vitamin-K antagonists for stroke prevention in atrial fibrillation? Lessons from the recent aspirin-controlled trials
    Verheugt, F. W. A.
    Jaspersfocks, J.
    Brouwer, M. A.
    EUROPEAN HEART JOURNAL, 2011, 32 : 672 - 672
12345